tiprankstipranks
Trending News
More News >
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market
Advertisement

Shield Therapeutics (STX) Technical Analysis

Compare
34 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is 0.32, suggesting Shield Therapeutics PLC is a Sell.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 7.47, while Shield Therapeutics PLC’s (STX) share price is 9.3p, making it a Buy.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 7.20, while Shield Therapeutics PLC’s (STX) share price is 9.3p, making it a Buy.

Shield Therapeutics (STX) Pivot Points

Nov 29, 2025, 01:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.20
7.70
8.40
8.90
9.60
10.10
10.80
Fibonacci
7.70
8.16
8.44
8.90
9.36
9.64
10.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Nov 29, 2025, 01:52 AM
Period
Simple
Exponential
MA5
8.25Buy
8.45Buy
MA10
7.47Buy
7.86Buy
MA20
7.14Buy
7.47Buy
MA50
7.42Buy
7.20Buy
MA100
6.62Buy
6.49Buy
MA200
4.71Buy
5.08Buy
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 7.86, while Shield Therapeutics PLC’s (STX) share price is 9.3p, making it a Buy.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 6.49, while Shield Therapeutics PLC’s (STX) share price is 9.3p, making it a Buy.
Shield Therapeutics PLC’s (STX) stock price is 9.3p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 7.42, creating a Buy signal.
Shield Therapeutics PLC’s (STX) stock price is 9.3p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 6.62, creating a Buy signal.
Shield Therapeutics PLC’s (STX) stock price is 9.3p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 4.71, creating a Buy signal.

Shield Therapeutics (STX) Technical Indicators

Nov 29, 2025, 01:52 AM
Name
Value
Implied Action
RSI (14)
77.34
Sell
STOCH (9,6)
89.66
Sell
STOCHRSI (14)
89.66
Sell
MACD (12,26)
0.32
Sell
ADX (14)
29.03
Neutral
Williams %R
-9.26
Sell
CCI (14)
271.61
Sell
ATR (14)
0.67
-
Ultimate Oscillator
65.63
Neutral
ROC
35.77
Buy
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 77.34, creating a Sell signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 29.03, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is 271.61, creating a Sell signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is 35.77, creating a Buy signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Buy.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 77.34, which suggests STX is a Sell.
      What is STX’s MACD?
      STX’s MACD is 0.32, which suggests STX is a Sell.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 8.25, which suggests STX is a Buy.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 7.14, which suggests STX is a Buy.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 7.42, which suggests STX is a Buy.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 4.71, which suggests STX is a Buy.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -9.26, which suggests STX is a Sell.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is 271.61, which suggests STX is a Sell.
                    What is the share price of Shield Therapeutics PLC?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis